Canadian Journal of Chemistry · 1983 · 12 citations · 1 references
MedicineMedicinal ChemistryOncologyEndocrine OncologyMolecular OncologyStructural BiologyHormone StructureSteroid StructureTumor ImagingX-ray CrystallographyEstrogen Metabolites
The E- and Z-isomers of an iodo-Tamoxifen 1 (1-(p-(β-dimethylaminoethoxy)phenyl)-2-(p-iodophenyl)-1-phenyl-1-butenes) have been prepared from the corresponding E- and Z-amino-Tamoxifens 2 (2-(p-aminophenyl)-1-(p-(β-dimethylaminoethoxy)phenyl)-1-phenyl-1-butenes) and the molecular structures have been determined from three dimensional X-ray data. Crystals of E-1 are triclinic, space group [Formula: see text], with Z = 2 in a cell of dimensions a = 10.714(2), b = 14.125(3), c = 8.240(2) Å, α = 95.78(1), β = 92.91(1), and γ = 71.41(1)°; those of Z-1 are monoclinic, space group P2 1 /n, with Z = 4 and cell dimensions a = 12.675(2), b = 19.553(3), c = 9.483(1) Å, and β = 92.22(1)°. Intensity data collected on an automated four circle diffractometer were used for full-matrix least-squares refinement on F, which converged for E-1 at R = 0.054, 2736 observations, and for Z-1 at R = 0.042, 3644 observations. The solution of these structures determines the configuration of these isomers as well as the respective amino precursors and allows an unambiguous assignment of the proton nmr spectra of 1, 2 and the Tamoxifens.
1
<i>International Tables for X-ray Crystallography</i>
Acta Crystallographica Section B · 1976 · 14.2K citations · Full text